Clinical Trial Update: Feasibility and Toxicity of Degarelix for Prostate Downsizing Prior to Permanent Seed Prostate Brachytherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating feasibility and toxicity of degarelix for downsizing before permanent seed prostate brachytherapy in prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• degarelix (degarelix)

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED